Skip to main content
Show full summary

Lord Mendelsohn to ask His Majesty's Government when the COVID-19 Therapeutics Clinical Review Panel held its last meeting; and whether the strategy to support at-risk patient cohorts has been recently reviewed, with particular reference to the accessibility of (1) Evusheld, (2) Paxlovid, and (3) other treatments.  HL4909

Question HL4909: tabled on 19 January 2023 and due for answer by 2 February 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask His Majesty's Government when the COVID-19 Therapeutics Clinical Review Panel held its last meeting; and whether the strategy to support at-risk patient cohorts has been recently reviewed, with particular reference to the accessibility of (1) Evusheld, (2) Paxlovid, and (3) other treatments.  HL4909
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.